We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.
ClinicalTrials.gov Menu

Use of SMSs to Improve Attendance to Cervical Cancer Follow-up Screening

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02509702
Recruitment Status : Completed
First Posted : July 28, 2015
Last Update Posted : December 29, 2021
Information provided by (Responsible Party):
Marianne Andersen, Odense University Hospital

Tracking Information
First Submitted Date  ICMJE June 15, 2015
First Posted Date  ICMJE July 28, 2015
Last Update Posted Date December 29, 2021
Actual Study Start Date  ICMJE August 17, 2015
Actual Primary Completion Date October 6, 2019   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures  ICMJE
 (submitted: December 28, 2021)
Effect of SMS intervention on attendance rate to follow-up screening appointment [ Time Frame: up to 14 months ]
The effect measure of the intervention is the 14-month follow-up attendance rate for HPV positive women. The number of women in the intervention group that attend follow-up screening will be compared to the the number of women that attend follow-up screening in the control group.
Original Primary Outcome Measures  ICMJE
 (submitted: July 25, 2015)
Effect of mHealth messages on attendance rate to check-up appointment [ Time Frame: 12 months ]
To assess the effect of mHealth messages, mHealth quizzes, and sms-reminders on HPV-positive women's attendance to check-up appointments at 12 months compared to standard of care.
Change History
Current Secondary Outcome Measures  ICMJE
 (submitted: December 28, 2021)
  • Acceptability of text message intervention [ Time Frame: Baseline + 2 years Follow-up (likert scale) ]
    6-point Likert scale (1: I do not like it at all - 6: I like it very much)
  • Acceptability of text message intervention [ Time Frame: 2 years ]
    Qualitative interviews. Open-ended
Original Secondary Outcome Measures  ICMJE Not Provided
Current Other Pre-specified Outcome Measures
 (submitted: December 28, 2021)
  • Cost-effectiveness of intervention [ Time Frame: Baseline + 14 months ]
    Incremental cost-effectiveness ratio
  • Knowledge of cervical cancer and screening [ Time Frame: Baselie + 14 months ]
    16 item true-false questionaire
Original Other Pre-specified Outcome Measures Not Provided
Descriptive Information
Brief Title  ICMJE Use of SMSs to Improve Attendance to Cervical Cancer Follow-up Screening
Official Title  ICMJE Text Messages to Increase Attendance to Follow-up Cervical Cancer Screening Appointments Among HPV Positive Tanzanian Women (Connected2Care)
Brief Summary This study evaluates the effect of the SMS intervention 'Connected2Care' on the attendance rate to cervical cancer screening follow-up appointments.
Detailed Description Connected2Care is a non-blinded, multicentre, parallel-group, randomised controlled trial. Tanzanian Women testing positive to HR HPV at inclusion are randomly assigned in an allocation ratio of 1:1 to the SMS intervention or the control group (standard care). In a period of 10 months, the intervention group will receive 15 one-directional health educative text messages and SMS-reminders for their appointment. The total sample size will be 700 with 350 women in each study arm. Primary outcome is attendance rate for follow-up. Secondary objectives are cost-effectiveness measured through incremental ratios and knowledge of cervical cancer by a 16-item true/false scale questionnaire at baseline and follow-up.
Study Type  ICMJE Interventional
Study Phase  ICMJE Not Applicable
Study Design  ICMJE Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Care Provider, Outcomes Assessor)
Primary Purpose: Screening
Condition  ICMJE Cervical Cancer
Intervention  ICMJE Behavioral: Connected to Care
10 health educative SMSs' sent once a month 5 SMS-reminders for follow-up appointment sent on days -14, -7, -1 pre- follow-up appointment, and +1, +7 post follow-up appointment
Study Arms  ICMJE
  • Experimental: Connected to Care
    The SMS intervention will consist of 15 text messages that will be sent to the intervention group over a period of 10 months. There will be two types of text messages: (1) educational text messages; and (2) SMS reminders for the follow-up appointment.
    Intervention: Behavioral: Connected to Care
  • No Intervention: Control
    The control group will receive standard care, which is a follow-up appointment at 14 months written on an appointment card.
Publications *

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
Recruitment Information
Recruitment Status  ICMJE Completed
Actual Enrollment  ICMJE
 (submitted: December 28, 2021)
Original Estimated Enrollment  ICMJE
 (submitted: July 25, 2015)
Actual Study Completion Date  ICMJE October 6, 2019
Actual Primary Completion Date October 6, 2019   (Final data collection date for primary outcome measure)
Eligibility Criteria  ICMJE

Inclusion Criteria:

  • Informed consent
  • HPV positive
  • Age 25 - 60 years
  • Private mobile phone

Exclusion Criteria:

  • Pregnant on day of enrolment
  • Menstruating on day of enrolment
  • Hysterectomy
  • Diagnosed with cervical pre-cancer within past 12 months
  • Diagnosed with cervical cancer
  • Invalid mobile phone number
  • Unreachable when trying to convey HPV positive result
Sex/Gender  ICMJE
Sexes Eligible for Study: Female
Ages  ICMJE 25 Years to 60 Years   (Adult)
Accepts Healthy Volunteers  ICMJE No
Contacts  ICMJE Contact information is only displayed when the study is recruiting subjects
Listed Location Countries  ICMJE Tanzania
Removed Location Countries  
Administrative Information
NCT Number  ICMJE NCT02509702
Other Study ID Numbers  ICMJE Connected2Care
Has Data Monitoring Committee No
U.S. FDA-regulated Product Not Provided
IPD Sharing Statement  ICMJE Not Provided
Current Responsible Party Marianne Andersen, Odense University Hospital
Original Responsible Party Same as current
Current Study Sponsor  ICMJE Marianne Andersen
Original Study Sponsor  ICMJE Same as current
Collaborators  ICMJE Not Provided
Investigators  ICMJE
Study Chair: Vibeke Rasch, MD University of Southern Denmark
Study Chair: Julius Mwaiselage, MD Ocean Road Cancer Institute
PRS Account Odense University Hospital
Verification Date December 2021

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP